| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer | EVP &CFO
4 companies
Meline David W is a Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $16.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | PACB Pacific Biosciences Of California, Inc. | Director | Buy | 40,000 | $4.40 | $176,160.00 | New | -56.9% | -68.9% | |
| Aug 10, 2022 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE | 164 | $173.66 | $28,480.67 | -5.4% | -5.5% | -42.5% | |
| May 10, 2022 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE | 156 | $133.71 | $20,859.35 | -5.7% | +38.3% | -1.1% | |
| Feb 10, 2022 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE | 619 | $158.89 | $98,354.15 | -20.6% | -23.1% | +5.5% | |
| Nov 25, 2019 | AMGN Amgen Inc | EVP &CFO | Sell | 8,737 | $234.36 | $2,047,603.32 | -15.0% | - | - |